Global Vinblastinesulphate (CAS 143-67-9) Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Vinblastinesulphate (CAS 143-67-9) market size will reach 23.47 Million USD in 2025 and is projected to reach 25.60 Million USD by 2032, with a CAGR of 1.25% (2025-2032). Notably, the China Vinblastinesulphate (CAS 143-67-9) market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Vinblastine sulfate, with the chemical formula C46H58N4O9S, is a potent medication used primarily in the treatment of various types of cancer. It belongs to a class of drugs known as vinca alkaloids, which are derived from the Madagascar periwinkle plant (Catharanthus roseus). Vinblastine sulfate works by interfering with the growth and division of cancer cells, ultimately leading to their destruction. It is commonly used to treat Hodgkin＇s disease, non-Hodgkin＇s lymphoma, testicular cancer, breast cancer, and certain types of lung cancer. Vinblastine sulfate is administered intravenously by healthcare professionals and is often used in combination with other chemotherapy drugs as part of a treatment regimen. While effective, vinblastine sulfate can cause various side effects, including nausea, vomiting, hair loss, bone marrow suppression, and peripheral neuropathy. It is important for patients receiving vinblastine sulfate to be closely monitored by their healthcare providers for both efficacy and potential adverse effects.
The major global manufacturers of Vinblastinesulphate (CAS 143-67-9) include Guangzhou Hanfang Pharmaceutical, Hainan Vinca Biological Medicine Technology, Guangzhou Person Pharmaceutical, Hainan Yueyang Biotechnology, Hubei Honch Pharmaceutical, Fine Chemicals Corporation, Hengtengfu Biological Products, Vinkem, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Vinblastinesulphate (CAS 143-67-9). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Vinblastinesulphate (CAS 143-67-9) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Vinblastinesulphate (CAS 143-67-9) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Vinblastinesulphate (CAS 143-67-9) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Vinblastinesulphate (CAS 143-67-9) Include:
Guangzhou Hanfang Pharmaceutical
Hainan Vinca Biological Medicine Technology
Guangzhou Person Pharmaceutical
Hainan Yueyang Biotechnology
Hubei Honch Pharmaceutical
Fine Chemicals Corporation
Hengtengfu Biological Products
Vinkem
Vinblastinesulphate (CAS 143-67-9) Product Segment Include:
＞98% Vinblastinesulphate
97-98% Vinblastinesulphate
Other
Vinblastinesulphate (CAS 143-67-9) Product Application Include:
Lymphoma
Lung Cancer
Breast & Ovarian Cancer
Leukemia
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Vinblastinesulphate (CAS 143-67-9) Capacity and Production Analysis
Chapter 3: Global Vinblastinesulphate (CAS 143-67-9) Industry PESTEL Analysis
Chapter 4: Global Vinblastinesulphate (CAS 143-67-9) Industry Porter's Five Forces Analysis
Chapter 5: Global Vinblastinesulphate (CAS 143-67-9) Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 6: Global Vinblastinesulphate (CAS 143-67-9) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 7: Global Vinblastinesulphate (CAS 143-67-9) Sales, Revenue, Price and Forecast by Product Type
Chapter 8: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 9: Industrial Chain Analysis, Vinblastinesulphate (CAS 143-67-9) Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 10: Research Findings and Conclusion
Chapter 11: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Vinblastinesulphate (CAS 143-67-9) market size will reach 23.47 Million USD in 2025 and is projected to reach 25.60 Million USD by 2032, with a CAGR of 1.25% (2025-2032). Notably, the China Vinblastinesulphate (CAS 143-67-9) market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Vinblastine sulfate, with the chemical formula C46H58N4O9S, is a potent medication used primarily in the treatment of various types of cancer. It belongs to a class of drugs known as vinca alkaloids, which are derived from the Madagascar periwinkle plant (Catharanthus roseus). Vinblastine sulfate works by interfering with the growth and division of cancer cells, ultimately leading to their destruction. It is commonly used to treat Hodgkin＇s disease, non-Hodgkin＇s lymphoma, testicular cancer, breast cancer, and certain types of lung cancer. Vinblastine sulfate is administered intravenously by healthcare professionals and is often used in combination with other chemotherapy drugs as part of a treatment regimen. While effective, vinblastine sulfate can cause various side effects, including nausea, vomiting, hair loss, bone marrow suppression, and peripheral neuropathy. It is important for patients receiving vinblastine sulfate to be closely monitored by their healthcare providers for both efficacy and potential adverse effects.
The major global manufacturers of Vinblastinesulphate (CAS 143-67-9) include Guangzhou Hanfang Pharmaceutical, Hainan Vinca Biological Medicine Technology, Guangzhou Person Pharmaceutical, Hainan Yueyang Biotechnology, Hubei Honch Pharmaceutical, Fine Chemicals Corporation, Hengtengfu Biological Products, Vinkem, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Vinblastinesulphate (CAS 143-67-9). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Vinblastinesulphate (CAS 143-67-9) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Vinblastinesulphate (CAS 143-67-9) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Vinblastinesulphate (CAS 143-67-9) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Vinblastinesulphate (CAS 143-67-9) Include:
Guangzhou Hanfang Pharmaceutical
Hainan Vinca Biological Medicine Technology
Guangzhou Person Pharmaceutical
Hainan Yueyang Biotechnology
Hubei Honch Pharmaceutical
Fine Chemicals Corporation
Hengtengfu Biological Products
Vinkem
Vinblastinesulphate (CAS 143-67-9) Product Segment Include:
＞98% Vinblastinesulphate
97-98% Vinblastinesulphate
Other
Vinblastinesulphate (CAS 143-67-9) Product Application Include:
Lymphoma
Lung Cancer
Breast & Ovarian Cancer
Leukemia
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Vinblastinesulphate (CAS 143-67-9) Capacity and Production Analysis
Chapter 3: Global Vinblastinesulphate (CAS 143-67-9) Industry PESTEL Analysis
Chapter 4: Global Vinblastinesulphate (CAS 143-67-9) Industry Porter's Five Forces Analysis
Chapter 5: Global Vinblastinesulphate (CAS 143-67-9) Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 6: Global Vinblastinesulphate (CAS 143-67-9) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 7: Global Vinblastinesulphate (CAS 143-67-9) Sales, Revenue, Price and Forecast by Product Type
Chapter 8: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 9: Industrial Chain Analysis, Vinblastinesulphate (CAS 143-67-9) Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 10: Research Findings and Conclusion
Chapter 11: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Vinblastinesulphate (CAS 143-67-9) Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Vinblastinesulphate (CAS 143-67-9) Product by Type
- 1.2.1 ＞98% Vinblastinesulphate
- 1.2.2 97-98% Vinblastinesulphate
- 1.2.3 Other
- 1.3 Vinblastinesulphate (CAS 143-67-9) Product by Application
- 1.3.1 Lymphoma
- 1.3.2 Lung Cancer
- 1.3.3 Breast & Ovarian Cancer
- 1.3.4 Leukemia
- 1.3.5 Other
- 1.4 Global Vinblastinesulphate (CAS 143-67-9) Market Revenue and Sales Analysis
- 1.4.1 Global Vinblastinesulphate (CAS 143-67-9) Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Vinblastinesulphate (CAS 143-67-9) Sales Market Sales Analysis (2020-2032)
- 1.4.3 Global Vinblastinesulphate (CAS 143-67-9) Market Sales Price Trend Analysis (2020-2032)
- 1.5 Vinblastinesulphate (CAS 143-67-9) Market Development Status and Trends
- 1.5.1 Vinblastinesulphate (CAS 143-67-9) Industry Development Status Analysis
- 1.5.2 Vinblastinesulphate (CAS 143-67-9) Industry Development Trends Analysis
- 2 Global Vinblastinesulphate (CAS 143-67-9) Capacity and Production Analysis
- 2.1 Global Vinblastinesulphate (CAS 143-67-9) Capacity, Production and Utilization (2020-2032)
- 2.2 Global Vinblastinesulphate (CAS 143-67-9) Production Growth Trend by Region: 2024 VS 2025 VS 2032
- 2.3 Global Vinblastinesulphate (CAS 143-67-9) Production by Region
- 2.3.1 Global Vinblastinesulphate (CAS 143-67-9) Production by Region (2020-2025)
- 2.3.2 Global Vinblastinesulphate (CAS 143-67-9) Production Forecast by Region (2026-2032)
- 2.3.3 Global Vinblastinesulphate (CAS 143-67-9) Production Market Share by Region (2020-2032)
- 3 Vinblastinesulphate (CAS 143-67-9) Market PESTEL Analysis
- 3.1 Political Factors Analysis
- 3.2 Economic Factors Analysis
- 3.3 Social Factors Analysis
- 3.4 Technological Factors Analysis
- 3.5 Environmental Factors Analysis
- 3.6 Legal Factors Analysis
- 4 Vinblastinesulphate (CAS 143-67-9) Market Porter's Five Forces Analysis
- 4.1 Competitive Rivalry
- 4.2 Threat of New Entrants
- 4.3 Bargaining Power of Suppliers
- 4.4 Bargaining Power of Buyers
- 4.5 Threat of Substitutes
- 5 Global Vinblastinesulphate (CAS 143-67-9) Market Analysis by Country
- 5.1 Global Vinblastinesulphate (CAS 143-67-9) Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 5.1.1 Global Vinblastinesulphate (CAS 143-67-9) Revenue and Market Share by Country (2020-2025)
- 5.1.2 Global Vinblastinesulphate (CAS 143-67-9) Revenue and Market Share Forecast by Country (2026-2032)
- 5.2 Global Vinblastinesulphate (CAS 143-67-9) Sales Analysis by Country: 2024 VS 2025 VS 2032
- 5.2.1 Global Vinblastinesulphate (CAS 143-67-9) Sales and Market Share by Country (2020-2025)
- 5.2.2 Global Vinblastinesulphate (CAS 143-67-9) Sales and Market Share Forecast by Country (2026-2032)
- 5.3 United States Vinblastinesulphate (CAS 143-67-9) Market Sales, Revenue and Growth Rate (2020-2032)
- 5.4 Germany Vinblastinesulphate (CAS 143-67-9) Market Sales, Revenue and Growth Rate (2020-2032)
- 5.5 Japan Vinblastinesulphate (CAS 143-67-9) Market Sales, Revenue and Growth Rate (2020-2032)
- 5.6 China Vinblastinesulphate (CAS 143-67-9) Market Sales, Revenue and Growth Rate (2020-2032)
- 5.7 France Vinblastinesulphate (CAS 143-67-9) Market Sales, Revenue and Growth Rate (2020-2032)
- 5.8 U.K. Vinblastinesulphate (CAS 143-67-9) Market Sales, Revenue and Growth Rate (2020-2032)
- 5.9 South Korea Vinblastinesulphate (CAS 143-67-9) Market Sales, Revenue and Growth Rate (2020-2032)
- 5.10 Canada Vinblastinesulphate (CAS 143-67-9) Market Sales, Revenue and Growth Rate (2020-2032)
- 5.11 Italy Vinblastinesulphate (CAS 143-67-9) Market Sales, Revenue and Growth Rate (2020-2032)
- 5.12 Russia Vinblastinesulphate (CAS 143-67-9) Market Sales, Revenue and Growth Rate (2020-2032)
- 5.13 Mexico Vinblastinesulphate (CAS 143-67-9) Market Sales, Revenue and Growth Rate (2020-2032)
- 5.14 Brazil Vinblastinesulphate (CAS 143-67-9) Market Sales, Revenue and Growth Rate (2020-2032)
- 5.15 India Vinblastinesulphate (CAS 143-67-9) Market Sales, Revenue and Growth Rate (2020-2032)
- 5.16 Vietnam Vinblastinesulphate (CAS 143-67-9) Market Sales, Revenue and Growth Rate (2020-2032)
- 5.17 Thailand Vinblastinesulphate (CAS 143-67-9) Market Sales, Revenue and Growth Rate (2020-2032)
- 5.18 South Africa Vinblastinesulphate (CAS 143-67-9) Market Sales, Revenue and Growth Rate (2020-2032)
- 6 Competition by Manufacturers
- 6.1 Global Vinblastinesulphate (CAS 143-67-9) Market Sales, Revenue and Sales Price by Key Manufacturers (2021-2025)
- 6.1.1 Global Vinblastinesulphate (CAS 143-67-9) Market Sales by Key Manufacturers (2021-2025)
- 6.1.2 Global Vinblastinesulphate (CAS 143-67-9) Market Revenue by Key Manufacturers (2021-2025)
- 6.1.3 Global Vinblastinesulphate (CAS 143-67-9) Average Sales Price by Manufacturers (2021-2025)
- 6.2 Vinblastinesulphate (CAS 143-67-9) Competitive Landscape Analysis and Market Dynamic
- 6.2.1 Vinblastinesulphate (CAS 143-67-9) Competitive Landscape Analysis
- 6.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 6.2.3 Market Dynamic
- 7 Vinblastinesulphate (CAS 143-67-9) Market Analysis by Type
- 7.1 Global Vinblastinesulphate (CAS 143-67-9) Market Revenue Analysis by Type
- 7.1.1 Global Vinblastinesulphate (CAS 143-67-9) Market Size Analysis by Type: 2024 & 2025 & 2032
- 7.1.2 Global Vinblastinesulphate (CAS 143-67-9) Revenue and Forecast Analysis by Type (2020-2032)
- 7.2 Global Vinblastinesulphate (CAS 143-67-9) Market Sales and Forecast Analysis by Type (2020-2032)
- 7.3 Global Vinblastinesulphate (CAS 143-67-9) Sales Price Trend Analysis by Type (2020-2032)
- 8 Key Companies Analysis
- 8.1 Guangzhou Hanfang Pharmaceutical
- 8.1.1 Guangzhou Hanfang Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 8.1.2 Guangzhou Hanfang Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Product Portfolio
- 8.1.3 Guangzhou Hanfang Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8.2 Hainan Vinca Biological Medicine Technology
- 8.2.1 Hainan Vinca Biological Medicine Technology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 8.2.2 Hainan Vinca Biological Medicine Technology Vinblastinesulphate (CAS 143-67-9) Product Portfolio
- 8.2.3 Hainan Vinca Biological Medicine Technology Vinblastinesulphate (CAS 143-67-9) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8.3 Guangzhou Person Pharmaceutical
- 8.3.1 Guangzhou Person Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 8.3.2 Guangzhou Person Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Product Portfolio
- 8.3.3 Guangzhou Person Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8.4 Hainan Yueyang Biotechnology
- 8.4.1 Hainan Yueyang Biotechnology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 8.4.2 Hainan Yueyang Biotechnology Vinblastinesulphate (CAS 143-67-9) Product Portfolio
- 8.4.3 Hainan Yueyang Biotechnology Vinblastinesulphate (CAS 143-67-9) Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8.5 Hubei Honch Pharmaceutical
- 8.5.1 Hubei Honch Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 8.5.2 Hubei Honch Phar
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
